NDRA ENDRA Life Sciences Inc. - Common Stock
NASDAQ · Health Care · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 14, 2026
$6.06
· of 52w range
· above low
· to high
$2.9652w low
$9.8552w high
Market Cap (MRQ)
$9M
P/E
-0.7
EPS
$-8.93
your badges
52W Range
$3–$10
Analyst Rating
BUY
Price Target
$25
P/E
-0.7
ROE
-376.5%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
NDRA Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$6.06
Market Cap (MRQ)
$9M
P/E
-0.7
EPS
$-8.93
ROE
-376.5%
52W Range
$3–$10
NDRA Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| Nov. 7, 2024 | 1-for-35 | Reverse |
| Aug. 20, 2024 | 1-for-50 | Reverse |
| Dec. 9, 2022 | 1-for-20 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue·2016-12-31 → 2020-12-31
EPS$-8.932023-12-31 → 2025-12-31
Free Cash Flow$-5M2018-12-31 → 2025-12-31
Net margin·2018-12-31 → 2018-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | NDRA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -0.75Y avg ≈-0.7 | ≈-0.7 | · | · | |
| P/B (MRQ) | 1.45Y avg ≈21104.1 | ≈21104.1 | 1.2 | Fair value | |
| Price / FCF | -1.45Y avg ≈-19611.4 | ≈-19611.4 | · | · | |
| Price / Cash Flow | -1.45Y avg ≈-19694.5 | ≈-19694.5 | · | · | |
| Price / Tangible Book | 3.25Y avg ≈21104.1 | ≈21104.1 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | NDRA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | -169.2%5Y avg ≈-154.8% | ≈-154.8% | -82.8% | Weak | |
| ROE | -376.5%5Y avg ≈-211.6% | ≈-211.6% | -129.4% | Weak |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | NDRA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 7.15Y avg ≈3.8 | ≈3.8 | 1.8 | Strong liquidity | |
| Quick Ratio | 1.0 | · | 1.1 | Strong liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-7.1%
Next Report
Nov 12, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 14, 2026 | $0.06 | $-0.86 | 107.0% |
| March 31, 2026 | May 15, 2026 | $-1.09 | $-1.25 | 13.1% |
| Dec. 31, 2025 | $-3.26 | $-1.25 | -159.8% | |
| Sept. 30, 2025 | $-2.10 | $-1.99 | -5.6% | |
| June 30, 2025 | $-1.71 | $-2.32 | 26.1% | |
| March 31, 2025 | $-1.86 | $-3.99 | 53.4% | |
| Dec. 31, 2024 | $-7.69 | $-4.18 | -83.8% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | $0 | $0 | $6.2K | $351.6K | $515.6K | |
| Cost of Revenue | · | · | · | · | · | $0 | $0 | $0 | $172.8K | · | |
| Gross Profit | · | · | · | · | · | $0 | $0 | $6.2K | $178.8K | $279.7K | |
| R&D Expense | $2M | $3M | $5M | $7M | $5M | $6M | $7M | $5M | $2M | $495.4K | |
| SG&A Expense | $4M | $7M | $5M | $5M | $5M | $5M | $4M | $4M | $3M | $2M | |
| Operating Expenses | $6M | $11M | $11M | $13M | $11M | $12M | $11M | $9M | $5M | $2M | |
| Operating Income | $-6M | $-11M | $-11M | $-13M | $-11M | $-12M | $-11M | $-9M | $-5M | $-2M | |
| Interest Expense | · | · | · | · | · | · | · | · | $42.6K | $72.0K | |
| Other Non-op | $-1M | $-690.8K | $460.5K | $-21.5K | $-41.5K | $8.8K | $-106.9K | $-48.0K | $-750.9K | · | |
| Pretax Income | $-7M | $-12M | $-10M | $-13M | $-11M | $-12M | $-13M | $-10M | $-5M | $-3M | |
| Income Tax | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-7M | $-12M | $-10M | $-13M | $-11M | $-12M | $-13M | $-10M | $-5M | $-3M | |
| EPS (Basic) | $-8.93 | $-56.94 | · | $-4.56 | $-5.55 | $-0.63 | · | · | · | · | |
| EPS (Diluted) | $-8.93 | $-56.94 | $-2766.85 | · | · | · | · | · | · | · | |
| Shares (Basic) | 787,020 | 202,106 | · | · | · | · | · | · | · | · | |
| Shares (Diluted) | 787,020 | 202,106 | 3,636 | · | · | · | · | · | · | · | |
| EBITDA | $-6M | $-11M | $-11M | $-13M | $-11M | $-11M | $-11M | $-9M | · | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $762.4K | $3M | · | $5M | $9M | $7M | $6M | $6M | $6M | $145.0K | |
| Receivables | · | · | · | · | · | · | · | $0 | $6.8K | $0 | |
| Inventory | $0 | $0 | $3M | $3M | $1M | $589.6K | $113.4K | $59.4K | $191.7K | $40.1K | |
| Prepaid Expense | $205.6K | $204.2K | $198.9K | $490.3K | $1M | $390.8K | $116.7K | $145.4K | $67.5K | $0 | |
| Other Current Assets | · | · | · | · | · | $6.0K | $130.7K | $273.3K | $14.2K | $10.5K | |
| Current Assets | $968.0K | $3M | $3M | $5M | $12M | $8M | $7M | $7M | $6M | $195.6K | |
| PP&E (Net) | $42.5K | $69.3K | $111.8K | $235.7K | $131.1K | $212.2K | $236.3K | $273.2K | $241.5K | $295.2K | |
| PP&E (Gross) | · | · | $587.0K | $738.7K | $605.2K | $718.9K | $679.2K | $679.2K | $579.2K | $571.3K | |
| Accum. Depreciation | $679.9K | $635.8K | $600.4K | $643.7K | $581.8K | $585.9K | $486.5K | $405.9K | $337.6K | $276.1K | |
| Other Non-current Assets | $6.0K | $6.0K | · | $6.0K | $6.0K | $6.0K | · | · | · | · | |
| Total Assets | $4M | $4M | $7M | $9M | $13M | $9M | $7M | $7M | $6M | $490.8K | |
| Accounts Payable | $383.0K | $269.7K | $360.4K | $614.0K | $791.1K | $402.9K | $1M | $631.5K | $780.3K | $227.7K | |
| Accrued Liabilities | $161.9K | · | · | · | · | · | · | · | $0 | $72.0K | |
| Short-term Debt | · | $0 | $28.5K | $28.5K | · | · | · | · | $0 | $50.0K | |
| Current Liabilities | $751.0K | $605.2K | $903.1K | $2M | $2M | $986.7K | $2M | $974.6K | $848.2K | $1M | |
| Capital Leases | $363.0K | $487.5K | $192.1K | $365.9K | $518.1K | $271.9K | $342.8K | $0 | · | · | |
| Total Liabilities | $2M | $2M | $1M | $2M | $2M | $2M | $2M | $974.6K | $848.2K | $1M | |
| Long-term Debt | · | $0 | $0 | $0 | $546.6K | · | · | · | · | · | |
| Total Debt | · | $0 | $28.5K | · | · | · | · | · | · | · | |
| Common Stock | $116 | $53 | $1 | $317 | $212 | $3.4K | $842 | $742 | $392 | $72 | |
| Paid-in Capital | $113M | $106M | $98M | $89M | $79M | $64M | $50M | $34M | $23M | $12M | |
| Retained Earnings | $-110M | $-103M | $-92M | $-82M | $-69M | $-57M | $-45M | $-28M | $-18M | $-13M | |
| Stockholders' Equity | $2M | $3M | $6M | $7M | $11M | $7M | $5M | $6M | $5M | $-893.8K | |
| Liabilities + Equity | $4M | $4M | $7M | $9M | $13M | $9M | $7M | $7M | $6M | $490.8K | |
| Shares Outstanding | 1,176,477 | 536,908 | 5,937 | 3,169,103 | 2,127,725 | 34,049,704 | 8,421,401 | 7,422,642 | 3,923,027 | 723,335 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $44.0K | $46.5K | $123.7K | $96.7K | $116.2K | $99.3K | $80.6K | $68.3K | $61.5K | $64.9K | |
| Stock-based Comp | $329.4K | $571.9K | $996.4K | $1M | $1M | $2M | · | · | · | · | |
| Deferred Tax | · | · | $0 | $0 | $0 | $0 | · | · | · | · | |
| Other Non-cash | $1M | · | · | $-886.8K | $-1M | $879.6K | $5M | $2M | · | · | |
| Operating Cash Flow | $-5M | $-7M | $-10M | $-13M | $-11M | $-11M | $-9M | $-8M | $-3M | $-1M | |
| CapEx | $17.3K | $16.0K | $33.9K | $202.6K | $45.0K | $75.3K | $43.6K | $100.0K | $7.9K | · | |
| Investing Cash Flow | $-3M | $-12.8K | $-24.7K | $-202.6K | $-45.0K | $-75.3K | $-43.6K | $-100.0K | $-7.9K | $0 | |
| Stock Issued | $1M | $5M | $6M | $8M | $11M | $7M | $125.0K | $8M | $9M | $5.0K | |
| Net Stock Activity | $1M | $1M | $6M | $8M | $11M | $7M | $125.0K | $8M | · | · | |
| Financing Cash Flow | $6M | $8M | $8M | $8M | $13M | $12M | $8M | $9M | $9M | $1M | |
| Taxes Paid | · | · | $0 | $0 | · | $0 | $0 | $0 | $0 | · | |
| Free Cash Flow | $-5M | $-7M | $-10M | $-13M | $-11M | $-11M | $-9M | $-8M | · | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | 100.0% | · | · | |
| Operating Margin | · | · | · | · | · | · | · | -146080.5% | · | · | |
| Net Margin | · | · | · | · | · | · | · | -158669.6% | · | · | |
| Pretax Margin | · | · | · | · | · | · | · | -158669.6% | · | · | |
| EBITDA Margin | · | · | · | · | · | · | · | -144974.0% | · | · | |
| ROA | -169.2% | -205.4% | -125.5% | -119.0% | · | -147.1% | -184.8% | -146.8% | · | · | |
| ROE | -376.5% | -251.1% | -185.3% | -151.4% | -93.8% | -223.2% | -431.8% | -338.4% | · | · | |
| ROIC | · | -422.5% | -185.0% | -182.6% | -106.6% | -160.4% | -227.8% | -144.3% | · | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 5.7 | 3.4 | 5.0 | · | 8.3 | 3.2 | 7.1 | · | · | |
| Quick Ratio | 1.0 | · | · | 2.9 | · | 7.3 | 3.0 | 6.6 | · | · | |
| Debt / Equity | · | 0.0 | 0.0 | · | · | · | · | · | · | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | · | |
| Inventory Turnover | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | · | |
| Receivables Turnover | · | · | · | · | · | · | · | 1.8 | · | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.92 | $4.77 | $0.54 | $2.27 | $0.25 | $0.21 | $0.57 | $0.84 | · | · | |
| Cash Flow / Share | $-6.58 | $-36.62 | · | · | · | · | · | · | · | · | |
| Cash / Share | $0.65 | · | · | $1.54 | $0.22 | $0.21 | $0.73 | $0.87 | · | · | |
| EPS (TTM) | $-8.93 | $-56.94 | $-2766.85 | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $6.2K | $351.6K | · | |
| Net Income TTM | $-7M | $-12M | $-10M | $-13M | $-11M | $-12M | $-13M | $-10M | $-5M | · | |
| Market Cap | $5M | $3M | $38.55B | $22.57B | $1.03T | $893.80B | $495.18B | $389.69B | · | · | |
| P/E | -0.5 | -0.1 | -1.3 | · | · | · | · | · | · | · | |
| P/S | · | · | · | · | · | · | · | 63117704.1 | · | · | |
| P/B | 2.4 | 1.3 | 6811.7 | 3133.0 | 95571.8 | 124670.8 | 104014.4 | 62368.1 | · | · | |
| P / Tangible Book | 2.4 | 1.3 | 6811.7 | 3133.0 | 95571.8 | 124670.7 | · | · | · | · | |
| P / Cash Flow | -1.0 | -0.5 | -4036.9 | -1767.7 | -92666.3 | -83171.0 | -57653.6 | -50592.6 | · | · | |
| P / FCF | -1.0 | -0.5 | -4022.6 | -1740.1 | -92292.9 | -82592.0 | -57362.5 | -49944.2 | · | · | |
| Earnings Yield | -197.1% | -909.6% | -74.6% | · | · | · | · | · | · | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $233.7K | $776.4K | $508.1K | $432.1K | $381.1K | $528.7K | $638.0K | $794.4K | $716.4K | $1M | $579.4K | $2M | $1M | $1M | $2M | $2M | |
| SG&A Expense | $1M | $1M | $1M | $893.3K | $851.2K | $871.6K | $4M | $631.4K | $1M | $2M | $730.6K | $1M | $1M | $1M | $1M | $1M | |
| Operating Expenses | $1M | $2M | $2M | $1M | $1M | $1M | $4M | $2M | $2M | $3M | $1M | $3M | $3M | $3M | $3M | $3M | |
| Operating Income | $-1M | $-2M | $-2M | $-1M | $-1M | $-1M | $-4M | $-2M | $-2M | $-3M | $-1M | $-3M | $-3M | $-3M | $-3M | $-3M | |
| Other Non-op | $2M | $862.3K | $-1M | $42.0K | $75.2K | $433.0K | $-762.9K | $65.5K | $1.7K | $4.8K | $47.9K | $-28.2K | $437.4K | $3.4K | $23.8K | $-23.0K | |
| Pretax Income | $159.9K | $-1M | $-3M | $-2M | $-1M | $-1M | $-4M | $-2M | $-2M | $-3M | $-1M | $-3M | $-3M | $-3M | $-3M | $-3M | |
| Income Tax | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $159.9K | $-1M | $-3M | $-2M | $-1M | $-1M | $-4M | $-2M | $-2M | $-3M | $-1M | $-3M | $-3M | $-3M | $-3M | $-3M | |
| EPS (Basic) | $0.12 | $-1.09 | $-3.25 | $-2.10 | $-1.71 | $-1.86 | $25.20 | $-9.54 | · | · | · | · | · | · | · | · | |
| EPS (Diluted) | $0.06 | $-1.09 | $-3.25 | $-2.10 | $-1.71 | $-1.86 | $25.20 | $-9.54 | · | · | · | · | · | · | · | · | |
| Shares (Basic) | 1,324,046 | 1,199,586 | · | 761,218 | 717,107 | 557,582 | · | 246,816 | · | · | · | · | · | · | · | · | |
| Shares (Diluted) | 2,475,261 | 1,199,586 | · | 761,218 | 717,107 | 557,582 | · | 246,816 | · | · | · | · | · | · | · | · | |
| EBITDA | $-1M | $-2M | · | $-1M | $-1M | $-1M | · | $-2M | $-2M | $-3M | · | $-3M | $-3M | $-3M | · | $-3M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2M | $356.5K | $762.4K | $794.0K | · | · | $3M | · | · | · | · | · | $5M | $2M | · | $8M | |
| Inventory | · | · | $0 | $0 | $0 | $0 | $0 | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Prepaid Expense | $47.1K | $180.2K | $205.6K | $254.7K | $44.3K | $115.3K | $204.2K | $217.1K | $312.7K | $135.8K | $198.9K | $305.9K | $506.9K | $428.5K | $490.3K | $914.3K | |
| Current Assets | $6M | $536.7K | $968.0K | $1M | $2M | $2M | $3M | $5M | $7M | $1M | $3M | $6M | $8M | $6M | $5M | $12M | |
| PP&E (Net) | $43.5K | $33.0K | $42.5K | $52.6K | $63.4K | $72.8K | $69.3K | $80.3K | $91.8K | $111.5K | $111.8K | $160.8K | $192.9K | $228.1K | $235.7K | $230.6K | |
| PP&E (Gross) | · | · | · | · | · | · | · | $580.0K | $580.0K | $591.0K | · | $658.7K | $658.7K | $765.7K | $738.7K | $733.5K | |
| Accum. Depreciation | $697.5K | $689.4K | $679.9K | $669.8K | · | $649.6K | $635.8K | $624.8K | $613.3K | $604.6K | $600.4K | $638.5K | $606.4K | $678.2K | $643.7K | $646.3K | |
| Other Non-current Assets | $6.0K | $6.0K | $6.0K | $6.0K | · | · | $6.0K | · | · | · | · | · | · | · | · | · | |
| Total Assets | $8M | $3M | $4M | $2M | $3M | $3M | $4M | $8M | $10M | $5M | $7M | $8M | $9M | $7M | $9M | $12M | |
| Accounts Payable | $465.0K | $456.8K | $383.0K | $252.5K | $282.0K | $223.6K | $269.7K | $279.4K | $300.4K | $521.6K | $360.4K | $419.1K | $414.9K | $524.0K | $614.0K | $636.7K | |
| Accrued Liabilities | $10.0K | $92.1K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Short-term Debt | · | · | · | · | · | · | · | $0 | $0 | $0 | $28.5K | $28.5K | $28.5K | · | $28.5K | · | |
| Current Liabilities | $786.6K | $835.4K | $751.0K | $800.3K | $576.6K | $565.8K | $605.2K | $814.0K | $1M | $1M | $903.1K | $2M | $2M | $2M | $2M | $2M | |
| Capital Leases | $290.6K | $327.3K | $363.0K | $396.5K | $429.3K | $461.2K | $487.5K | $49.8K | $98.4K | $145.8K | $192.1K | $237.2K | $281.2K | $324.1K | $365.9K | $405.8K | |
| Total Liabilities | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $2M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | $0 | $0 | · | $281.2K | $324.1K | $0 | $434.3K | |
| Total Debt | · | · | · | · | · | · | · | $0 | $0 | $0 | · | $28.5K | $28.5K | · | · | · | |
| Common Stock | $148 | $122 | $116 | $77 | $74 | $55 | $53 | $53 | $7.2K | $1.1K | $1 | $841 | $748 | $317 | $317 | $6.3K | |
| Paid-in Capital | $118M | $114M | $113M | $107M | $107M | $106M | $106M | $106M | $106M | $98M | $98M | $96M | $94M | $89M | $89M | $89M | |
| Retained Earnings | $-112M | $-112M | $-110M | $-107M | $-106M | $-104M | $-103M | $-99M | $-97M | $-95M | $-92M | $-90M | $-87M | $-85M | $-82M | $-79M | |
| Stockholders' Equity | $6M | $2M | $2M | $171.4K | $1M | $2M | $3M | $7M | $9M | $4M | $6M | $5M | $7M | $4M | $7M | $10M | |
| Liabilities + Equity | $8M | $3M | $4M | $2M | $3M | $3M | $4M | $8M | $10M | $5M | $7M | $8M | $9M | $7M | $9M | $12M | |
| Shares Outstanding | 1,499,838 | 1,240,751 | 1,176,477 | 786,902 | 752,390 | 562,213 | 536,908 | 534,863 | 72,439,526 | 10,914,447 | 5,937 | 8,411,777 | 7,481,603 | 3,169,103 | 3,169,103 | 63,174,455 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $8.2K | $9.5K | $10.1K | $10.8K | $9.4K | $13.8K | $11.0K | $11.5K | $8.7K | $15.3K | $21.9K | $32.1K | $35.3K | $34.5K | $32.1K | $23.8K | |
| Stock-based Comp | $541.9K | $574.5K | $12.9K | $144.7K | $39.5K | $83.0K | $104.7K | $-36.8K | $186.6K | $317.5K | $250.6K | $252.7K | $255.9K | $237.3K | $290.8K | $309.2K | |
| Other Non-cash | · | $-392.2K | · | · | · | · | · | · | · | · | · | · | · | $164.1K | · | · | |
| Operating Cash Flow | $-927.6K | $-1M | $-2M | $-1M | $-1M | $-1M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-2M | $-3M | $-3M | $-3M | |
| CapEx | · | · | $0 | $0 | $0 | $17.3K | $0 | $0 | $-11.0K | $27.0K | $6.9K | $0 | $0 | $27.0K | $38.6K | $14.9K | |
| Investing Cash Flow | $2M | $450.0K | $-3M | $0 | $0 | $-17.3K | $0 | $0 | $11.0K | $-23.8K | $2.3K | $0 | $0 | $-27.0K | $-38.6K | $-14.9K | |
| Net Debt Issued | · | · | · | · | · | $0 | · | · | · | $-28.5K | · | · | · | · | · | · | |
| Stock Issued | $93.9K | $263.7K | $65.6K | $149.5K | $857.4K | $145.8K | $4M | $0 | $728.5K | $420.0K | $656.8K | $1M | $5M | $0 | $0 | $0 | |
| Net Stock Activity | · | $263.7K | · | · | · | $145.8K | · | · | · | $420.0K | · | · | · | $0 | · | · | |
| Financing Cash Flow | $4M | $263.7K | $5M | $149.5K | $857.4K | $145.8K | $0 | $1.7K | $7M | $468.9K | $2M | $1M | $5M | $0 | $0 | $0 | |
| Net Change in Cash | · | · | · | · | · | · | · | · | · | · | · | · | $2M | $-3M | · | $-3M | |
| Taxes Paid | · | · | · | · | $0 | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | |
| Free Cash Flow | · | · | · | · | · | $-1M | · | · | · | $-2M | · | · | · | $-3M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | 3.0% | -39.7% | · | -30.9% | -18.5% | -25.2% | · | -29.5% | -22.7% | -47.4% | · | -31.1% | -20.8% | -33.5% | · | -24.9% | |
| ROE | 4.1% | -74.1% | · | -47.1% | -23.4% | -38.0% | · | -39.9% | -28.0% | -67.7% | · | -40.3% | -25.2% | -43.4% | · | -29.4% | |
| ROIC | · | · | · | · | -88.3% | -83.8% | · | -22.9% | -24.8% | -75.2% | · | -59.9% | -43.0% | -65.3% | · | -33.5% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.1 | 0.6 | · | 1.3 | 3.2 | 3.9 | · | 6.1 | 5.0 | 1.0 | · | 2.9 | 4.0 | 3.0 | · | 6.8 | |
| Quick Ratio | 2.2 | 0.4 | · | 1.0 | · | · | · | · | · | · | · | · | 2.4 | 1.3 | · | 4.7 | |
| Debt / Equity | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | · |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $4.21 | $1.44 | · | $0.22 | $1.96 | $3.12 | · | $12.35 | $0.12 | $0.34 | · | $0.62 | $0.93 | $1.42 | · | $0.16 | |
| Cash Flow / Share | · | $-0.93 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Cash / Share | $1.16 | $0.29 | · | $1.01 | · | · | · | · | · | · | · | · | $0.64 | $0.74 | · | $0.13 | |
| EPS (TTM) | $-6.38 | $-8.15 | · | $19.53 | $12.09 | · | · | · | · | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | |
| Net Income TTM | $-6M | $-7M | · | $-8M | $-9M | $-10M | · | $-9M | $-10M | $-10M | · | $-12M | $-12M | $-13M | · | $-13M | |
| Market Cap | $8M | $6M | · | $4M | $3M | $2M | · | $4M | $12.30B | $11.08B | · | $16.34B | $18.33B | $12.70B | · | $676.60B | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | · | $18.33B | · | · | · | |
| P/E | -0.8 | -0.6 | · | 0.3 | 0.3 | · | · | · | · | · | · | · | · | · | · | · | |
| P/B | 1.3 | 3.2 | · | 24.7 | 1.8 | 1.3 | · | 0.6 | 1367.2 | 2995.6 | · | 3144.5 | 2644.8 | 2822.9 | · | 66311.5 | |
| P / Tangible Book | 1.3 | 3.2 | · | 24.7 | 1.8 | 1.3 | · | 0.6 | 1367.2 | 2995.6 | · | 3144.5 | 2644.8 | 2822.9 | · | 66311.5 | |
| P / Cash Flow | · | -5.2 | · | · | · | -1.8 | · | · | · | -5166.3 | · | · | · | -5066.2 | · | · | |
| Earnings Yield | -119.7% | -175.3% | · | 363.0% | 344.4% | · | · | · | · | · | · | · | · | · | · | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Net Income | $-7M | $-12M | $-10M | $-13M | $-11M |
| Diluted EPS | $-8.93 | $-56.94 | $-2766.85 | · | · |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debt / Equity | · | 0.0 | 0.0 | · | · |
| Current Ratio | 1.3 | 5.7 | 3.4 | 5.0 | · |
| Quick Ratio | 1.0 | · | · | 2.9 | · |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-5M | $-7M | $-10M | $-13M | $-11M |
Institutional owners (13F) 11 filers · $878K total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
11
Value held
$878K
New positions
3
Exited positions
1
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 3 (-1 vs prior Q) | 1 (-1 vs prior Q) | 2 (+1 vs prior Q) | 2 (+1 vs prior Q) | +64K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Altium Capital Management LLC | $315,920 | 59,272 | 36.00% | Shares |
| CITADEL ADVISORS LLC | $159,495 | 29,924 | 18.17% | Shares |
| CITIZENS FINANCIAL GROUP INC/RI | $151,372 | 28,400 | 17.25% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $79,470 | 14,910 | 9.06% | Shares |
| VANGUARD GROUP INC | $58,604 | 12,937 | 6.68% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $53,945 | 10,121 | 6.15% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $39,117 | 7,339 | 4.46% | Shares |
| MORGAN STANLEY | $18,900 | 3,546 | 2.15% | Shares |
| UBS Group AG | $362 | 68 | 0.04% | Shares |
| Tower Research Capital LLC (TRC) | $309 | 58 | 0.04% | Shares |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $101 | 19 | 0.01% | Shares |
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Anthony DiGiandomenico ×2 filings | June 29, 2026 | 9.90% | Amendment | M&A / sale | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 12 insiders · 7 officers · 6 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Alexander Y Tokman | Chief Executive Officer | March 2, 2026 A | 101,926 | 0 | 0 | $0 |
| Francois Roger Michelon | Chief Executive Officer | Jan. 30, 2023 A | 97,191 | 0 | 0 | $0 |
| Richard Jacroux | Chief Financial Officer | March 2, 2026 A | 33,461 | 0 | 0 | $0 |
| David R. Wells | Chief Financial Officer | April 5, 2021 A | 80,003 | 0 | 0 | $0 |
| Michael Milos Thornton | Chief Technology Officer | May 18, 2023 P | 34,139 | 0 | 0 | $0 |
| Irina Pestrikova | Senior Director, Finance | Jan. 30, 2023 A | · | 0 | 0 | $0 |
| Renaud Bertrand Maloberti | Chief Commercial Officer | March 28, 2022 A | 1,580 | 0 | 0 | $0 |
| Lou Basenese | Director | Jan. 21, 2026 A | 65,709 | 0 | 0 | $0 |
| Michael Harsh | Director | Jan. 21, 2026 A | 65,710 | 0 | 0 | $0 |
| Anthony DiGiandomenico | Director | Jan. 21, 2026 A | 136,589 | 0 | 0 | $0 |
| Sanjiv Sam Gambhir | Director | April 9, 2020 A | 42,857 | 0 | 0 | $0 |
| UBS Group AG | · | Aug. 27, 2024 P | 146,012 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 1 ETF
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0.00% | 7,339 SH | Aug. 19, 2026 | Daily |
NDRA Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 7 analysts
BUY
Median target
$25.00
+312.5%
2 28.6%
Strong Buy
4 57.1%
Buy
1 14.3%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
1 analysts · 2026-10-04Mean target $25.00 +312.5%
Low$25.00
Mean$25.00
High$25.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| NDRA | $5M | -0.5 | · | · | -376.5% | · |
| AEMD | $3M | -0.2 | · | · | -134.5% | · |
| NMTC | · | -9.9 | 163.5% | · | · | · |
| BMRA | · | -1.8 | -16.2% | · | · | · |
| CODX | $11M | -0.1 | -84.1% | -7533.6% | -151.8% | 64.3% |
| AMIX | · | · | · | · | · | · |
| INBS | $7M | -0.3 | 38.1% | -294.9% | -292.2% | 48.6% |
| NVNO | $210.6K | -0.0 | · | · | -64.7% | · |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | · |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 14, 2026